Literature DB >> 3702152

Modification of cisplatin toxicity by antioxidants.

K Sugihara, M Gemba.   

Abstract

cis-Diamminedichloroplatinum II (cisplatin) is a potent anticancer chemotherapeutic agent. The major limitation in its use is nephrotoxicity, caused by an unknown mechanism. Injection of cisplatin into rats caused a decrease in body weight and an increase in blood urea nitrogen (BUN). These effects were modified by giving a radical scavenger, alpha-tocopherol, before the cisplatin injection. N-N'-diphenyl-p-phenylenediamine, another powerful radical scavenger, also attenuated the increase in BUN induced by cisplatin. These results suggest that the toxic effects of cisplatin may be related to free radical induced damage.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3702152     DOI: 10.1254/jjp.40.353

Source DB:  PubMed          Journal:  Jpn J Pharmacol        ISSN: 0021-5198


  13 in total

1.  Protection against cisplatin-induced lipid peroxidation and kidney damage by procaine in rats.

Authors:  L F Zhong; J G Zhang; M Zhang; S L Ma; Y X Xia
Journal:  Arch Toxicol       Date:  1990       Impact factor: 5.153

2.  Protection effects of procaine on oxidative stress and toxicities of renal cortical slices from rats caused by cisplatin in vitro.

Authors:  J G Zhang; L F Zhong; M Zhang; Y X Xia
Journal:  Arch Toxicol       Date:  1992       Impact factor: 5.153

3.  The mode of cisplatin-induced cell death in CYP2E1-overexpressing HepG2 cells: modulation by ERK, ROS, glutathione, and thioredoxin.

Authors:  Yongke Lu; Arthur Cederbaum
Journal:  Free Radic Biol Med       Date:  2007-07-06       Impact factor: 7.376

4.  Iron- and ascorbic acid-induced lipid peroxidation in renal microsomes isolated from rats treated with platinum compounds.

Authors:  J Hannemann; J Duwe; K Baumann
Journal:  Cancer Chemother Pharmacol       Date:  1991       Impact factor: 3.333

5.  Protective effect of piperacillin against the nephrotoxicity of cisplatin in rats.

Authors:  T Hayashi; Y Watanabe; K Kumano; R Kitayama; T Muratani; T Yasuda; I Saikawa; J Katahira; T Kumada; K Shimizu
Journal:  Antimicrob Agents Chemother       Date:  1989-04       Impact factor: 5.191

6.  Redox control of resistance to cis-diamminedichloroplatinum (II) (CDDP): protective effect of human thioredoxin against CDDP-induced cytotoxicity.

Authors:  T Sasada; S Iwata; N Sato; Y Kitaoka; K Hirota; K Nakamura; A Nishiyama; Y Taniguchi; A Takabayashi; J Yodoi
Journal:  J Clin Invest       Date:  1996-05-15       Impact factor: 14.808

7.  Induction of emesis in Suncus murinus by pyrogallol, a generator of free radicals.

Authors:  Y Torii; H Saito; N Matsuki
Journal:  Br J Pharmacol       Date:  1994-02       Impact factor: 8.739

8.  Thioredoxin interacting protein and its association with clinical outcome in gastro-oesophageal adenocarcinoma.

Authors:  Caroline M Woolston; Srinivasan Madhusudan; Irshad N Soomro; Dileep N Lobo; Alexander M Reece-Smith; Simon L Parsons; Stewart G Martin
Journal:  Redox Biol       Date:  2013-05-23       Impact factor: 11.799

9.  Oxidative stress induced in nurses by exposure to preparation and handling of antineoplastic drugs in Mexican hospitals: a multicentric study.

Authors:  Leobardo Manuel Gómez-Oliván; Gerardo Daniel Miranda-Mendoza; Paula Anel Cabrera-Galeana; Marcela Galar-Martínez; Hariz Islas-Flores; Nely Sanjuan-Reyes; Nadia Neri-Cruz; Sandra García-Medina
Journal:  Oxid Med Cell Longev       Date:  2014-02-26       Impact factor: 6.543

10.  Evaluation of nephroprotective and immunomodulatory activities of antioxidants in combination with cisplatin against murine visceral leishmaniasis.

Authors:  Meenakshi Sharma; Rakesh Sehgal; Sukhbir Kaur
Journal:  PLoS Negl Trop Dis       Date:  2012-05-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.